<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="7363">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03011073</url>
  </required_header>
  <id_info>
    <org_study_id>EPIC</org_study_id>
    <nct_id>NCT03011073</nct_id>
  </id_info>
  <brief_title>Evaluation of New Items in Cardiac Echography</brief_title>
  <acronym>EPIC</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Paris Saint Joseph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier Paris Saint Joseph</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Paris Saint Joseph hospital has just acquired a new echocardiography EPIC . This new system
      has image processing and left ventricular function quantification software which are
      different from the precedent model Philips IE33.Left ventricular function quantification and
      myocardial distortion are the main medical examination influencing doctor's decisions.

      EPIC can evaluate and quantify the cardiac ejection fraction via new software. Myocardial
      distortion quantification software also has been modified with new cut off and different
      calculation method.

      The aim of this study is to compare the quality of images and the quantification of cardiac
      ejection fraction with these new software in order to choose the more reliable and
      reproducible for patient.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2017</start_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac left ejection fraction</measure>
    <time_frame>Day 1</time_frame>
    <description>Evaluation of left ejection fraction by 3D</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Echographic images evaluation</measure>
    <time_frame>day 1</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Cardiac Echography</condition>
  <condition>Cardiac Ultrasound</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patient who have prescription to do an cardiac ultrasound
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient accepting to stay 15 min more

          -  Age &gt; 18 years old

        Exclusion Criteria:

          -  patient not accepting this procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Philippe GARCON, MD</last_name>
    <phone>+33 144127693</phone>
    <email>pgarcon@hpsj.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Helene BEAUSSIER, PharmD PhD</last_name>
    <phone>+33 144127038</phone>
    <email>hbeaussier@hpsj.fr</email>
  </overall_contact_backup>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 4, 2017</lastchanged_date>
  <firstreceived_date>January 3, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
